Aurora Kinase A Degradation as a Novel Therapeutic Entry Point for Neuroblastoma
Time: 3:45 pm
day: Conference Day One
Details:
- Learn how Aurora Kinase A is a validated target in neuroblastoma
- Development of selective Aurora Kinase A PROTACs
- Discussion of an entry point for unique drug combination treatments
